Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Cash from Investing Activities (2019 - 2026)

Pliant Therapeutics has reported Cash from Investing Activities over the past 8 years, most recently at -$4.1 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 105.93% to -$4.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $61.1 million through Mar 2026, down 59.26% year-over-year, with the annual reading at $134.3 million for FY2025, 4.31% down from the prior year.
  • Cash from Investing Activities was -$4.1 million for Q1 2026 at Pliant Therapeutics, down from $1.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $69.1 million in Q1 2025 and troughed at -$178.3 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is $20.0 million (2022), against an average of -$393294.1.
  • Year-over-year, Cash from Investing Activities crashed 11478.71% in 2023 and then soared 231.59% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $20.0 million in 2022, then surged by 59.43% to $31.9 million in 2023, then rose by 22.59% to $39.1 million in 2024, then crashed by 95.48% to $1.8 million in 2025, then tumbled by 331.9% to -$4.1 million in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Cash from Investing Activities are -$4.1 million (Q1 2026), $1.8 million (Q4 2025), and $27.9 million (Q3 2025).